|
|
Oslo Innovation Center, Gaustadalleen 21
Oslo, N-0349 Norway
phone:(47) 22 95 80 14
fax:(47) 22 95 80 98
|
|
| Symbol |
Private |
| Founded |
2000 |
| Employees |
|
|
|
| www.optinose.no
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Devices for nasal delivery of drugs and vaccines. |
|
| Management |
| Helena K Djupesland, M.B.A., Chief Executive Officer; Per G Djupesland, M.D., Ph.D., Chief Scientific Officer; Tony Flint, Head of QA/Regulatory Affairs |
| |
|
|
| |
|
| Keywords |
| hinosinusitis, migraine, parkinson, sexual dysfunction, migraine |
|
|
|
| Description |
|
OptiNose develops devices for nasal delivery of drugs and vaccines. |
|
| Technology / Differentiation |
| The OptiNose device can deliver drug to the upper posterior segment of the nose where it can access the entrances to the sinuses, to treat rhinitis and sinusitis. The company's technology exploits a natural reflex that functionally isolates the nasal circuit from the lungs during delivery. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members